HPV vaccine not cost-effective for adults age 26 to 45, study finds

Vaccination against human papillomavirus provides limited health benefits for adults aged 26 years and older at a high cost to the healthcare system, according to a study published Thursday by PLOS Medicine.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news